Evidence map›Paper›PMID 38500557›Full record

ArticleMaterials today. Bio2024

Cascaded controlled delivering growth factors to build vascularized and osteogenic microenvironment for bone regeneration.

Haifei Cao, Shuangjun He, Mingzhou Wu, Lihui Hong, Xiaoxiao Feng, Xuzhu Gao, Hongye Li, Mingming Liu, Nanning Lv

Open access · goldAbstract read
In one paragraph

Article in Materials today. Bio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Biocompatible Mesoporous Materials for Bone Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Haifei CaoDepartment of Orthopaedics, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, 264000, China.
Shuangjun HeDepartment of Orthopedic Surgery, Affiliated Danyang Hospital of Nantong University, The People's Hospital of Danyang, Danyang, 212300, China.
Mingzhou WuDepartment of Orthopedic Surgery, Taicang Hospital of Traditional Chinese Medicine, Taicang, 215400, China.
Lihui HongDepartment of Orthopedic Surgery, The Affiliated Lianyungang Clinical College of Xuzhou Medical University (The Second People's Hospital of Lianyungang), Lianyungang, 222003, China.
Xiaoxiao FengDepartment of Orthopedic Surgery, The Affiliated Lianyungang Clinical College of Xuzhou Medical University (The Second People's Hospital of Lianyungang), Lianyungang, 222003, China.
Xuzhu GaoDepartment of Orthopedic Surgery, The Affiliated Lianyungang Clinical College of Xuzhou Medical University (The Second People's Hospital of Lianyungang), Lianyungang, 222003, China.
Hongye LiDepartment of Orthopedic Surgery, The Affiliated Lianyungang Clinical College of Xuzhou Medical University (The Second People's Hospital of Lianyungang), Lianyungang, 222003, China.
Mingming LiuDepartment of Orthopedic Surgery, The Affiliated Lianyungang Clinical College of Xuzhou Medical University (The Second People's Hospital of Lianyungang), Lianyungang, 222003, China.
Nanning LvDepartment of Orthopedic Surgery, The Affiliated Lianyungang Clinical College of Xuzhou Medical University (The Second People's Hospital of Lianyungang), Lianyungang, 222003, China.
Xuzhou Medical College · CNBinzhou Medical University · CNNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The process of bone regeneration is intricately regulated by various cytokines at distinct stages. The establishment of early and efficient vascularization, along with the maintenance of a sustained osteoinductive microenvironment, plays a crucial role in the successful utilization of bone repair materials. This study aimed to develop a composite hydrogel that would facilitate the creation of an osteogenic microenvironment for bone repair. This was achieved by incorporating an early rapid release of VEGF and a sustained slow release of BMP-2. Herein, the Schiff base was formed between VEGF and the composite hydrogel, and VEGF could be rapidly released to promote vascularization in response to the early acidic bone injury microenvironment. Furthermore, the encapsulation of BMP-2 within mesoporous silica nanoparticles enabled a controlled and sustained release, thereby facilitating the process of bone repair. Our developed composite hydrogel released more than 80% of VEGF and BMP-2 in the acidic medium, which was significantly higher than that in the neutral medium (about 60%). Moreover, the composite hydrogel demonstrated a significant improvement in the migratory capacity and tube formation ability of human umbilical vein endothelial cells (HUVECs). Furthermore, the composite hydrogel exhibited an augmented ability for osteogenesis, as confirmed by the utilization of ALP staining, alizarin red staining, and the upregulation of osteogenesis-related genes. Notably, the composite hydrogel displayed substantial osteoinductive properties, compared with other groups, the skull defect in the composite hydrogels combined with BMP-2 and VEGF was full of new bone, basically completely repaired, and the BV/TV value was greater than 80%. The outcomes of animal experiments demonstrated that the composite hydrogel effectively promoted bone regeneration in cranial defects of rats by leveraging the synergistic effect of an early rapid release of VEGF and a sustained slow release of BMP-2, thereby facilitating vascularized bone regeneration. In conclusion, our composite hydrogel has demonstrated promising potential for vascularized bone repair through the enhancement of angiogenesis and osteogenic microenvironment.

Indexed as

Bone regenerationComposite hydrogelControlled releaseDrug deliveryVascularization

Identifiers

PMID38500557
PMCPMC10945171
OpenAlexW4392303380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.